Top Markets
#1 Black Phoenix Black Phoenix +355.53%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +65.70%
#4 Gold Park Gold Park +62.71%
#5 OpenEden OpenEden +56.54%
#6 BasedHype BasedHype +27.42%
#7 Avantis Avantis +22.22%
#8 Cryptopia Cryptopia +21.54%
#9 Acurast Acurast +18.38%
#10 Humanity Humanity +17.96%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Classement en actions #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
Prix de l'action
$0.00162013
Dernière synchronisation: 2025-01-03
Capitalisation boursière
$156.25K
Changement (1 jour)
0.36%
Changement (1 an)
0.00%
Pays
SE
Échange Cyxone AB (publ) (CYXO)

Catégorie

Healthcare
Historique du prix de l'action pour Cyxone AB (publ) (CYXO)
Prix de clôture le plus élevé : $0.00 le 2025-01-01

Prix de clôture le plus bas : $0.50 le 2016-06-01
Historique du prix de l'action de Cyxone AB (publ) de 2016 à 2026
Performance annuelle du prix de l'action
Année Performance
2025 -8.09%
2024 -82.58%
2023 -77.33%
2022 -83.86%
2021 -39.25%
2020 12.33%
2019 61.54%
2018 -80.08%
2017 88.25%
2016 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE